{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:15Z","timestamp":1791415935626,"version":"4.3.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13071-015-0738-0","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T01:01:50Z","timestamp":1424653310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Prophylactic and therapeutic DNA vaccines against Chagas disease"],"prefix":"10.1186","volume":"8","author":[{"given":"Minerva","family":"Arce-Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Rios-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia del Carmen","family":"Carrillo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mart\u00ednez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Rodr\u00edguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"key":"738_CR1","unstructured":"World Health Organization. Weekly epidemiological record. Geneve, Switzerland 2012;87:509-26. Available from: http:\/\/www.who.int\/wer"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0002-8703(94)90521-5","volume":"127","author":"R Viotti","year":"1994","unstructured":"Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J. 1994;127:151\u201362.","journal-title":"Am Heart J"},{"key":"738_CR3","first-page":"1","volume":"25","author":"L Murcia","year":"2012","unstructured":"Murcia L, Carrilero B, Segovia M. Limitations of currently available Chagas disease chemotherapy. Rev Esp Quimioter. 2012;25:1\u20133.","journal-title":"Rev Esp Quimioter"},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijantimicag.2011.03.004","volume":"38","author":"F Astelbauer","year":"2011","unstructured":"Astelbauer F, Walochnik J. Antiprotozoal compounds: state of the art and new developments. Int J Antimicrob Agents. 2011;38:118\u201324.","journal-title":"Int J Antimicrob Agents"},{"key":"738_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","volume":"19","author":"JA Urbina","year":"2003","unstructured":"Urbina JA, Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 2003;19:495\u2013501.","journal-title":"Trends Parasitol"},{"key":"738_CR6","doi-asserted-by":"publisher","first-page":"90520","DOI":"10.1155\/2007\/90520","volume":"2007","author":"E Dumonteil","year":"2007","unstructured":"Dumonteil E. DNA vaccines against protozoan parasites: opportunities and challenges. J Biomed Biotechnol. 2007;2007:90520.","journal-title":"J Biomed Biotechnol"},{"key":"738_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-94-007-7305-9_2","volume":"74","author":"D Smirlis","year":"2014","unstructured":"Smirlis D, Soares MB. Selection of molecular targets for drug development against trypanosomatids. Subcell Biochem. 2014;74:43\u201376.","journal-title":"Subcell Biochem"},{"key":"738_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1017\/S0031182013000292","volume":"140","author":"MN Soeiro","year":"2013","unstructured":"Soeiro MN, Werbovetz K, Boykin DW, Wilson WD, Wang MZ, Hemphill A. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology. 2013;140:929\u201351.","journal-title":"Parasitology"},{"key":"738_CR9","first-page":"195","volume":"74","author":"DL Montgomery","year":"1997","unstructured":"Montgomery DL, Ulmer JB, Donnelly JJ, Liu MA. DNA Vaccines. Pharmacol Ther. 1997;74:195\u2013205.","journal-title":"Pharmacol Ther"},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/156652311798192815","volume":"11","author":"C Coban","year":"2011","unstructured":"Coban C, Kobiyama K, Aoshi T, Takeshita F, Horii T, Akira S, et al. Novel strategies to improve DNA vaccine immunogenicity. Curr Gene Ther. 2011;11:479\u201384.","journal-title":"Curr Gene Ther"},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"e92643","DOI":"10.1371\/journal.pone.0092643","volume":"9","author":"E Prompetchara","year":"2014","unstructured":"Prompetchara E, Ketloy C, Keelapang P, Sittisombut N, Ruxrungtham K. Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines. PLoS ONE. 2014;9:e92643.","journal-title":"PLoS ONE"},{"key":"738_CR12","doi-asserted-by":"publisher","first-page":"e76407","DOI":"10.1371\/journal.pone.0076407","volume":"8","author":"JL Dutton","year":"2013","unstructured":"Dutton JL, Li B, Woo WP, Marshak JO, Xu Y, Huang ML, et al. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice. PLoS ONE. 2013;8:e76407.","journal-title":"PLoS ONE"},{"key":"738_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/cgt.2013.65","volume":"20","author":"N Obeng-Adjei","year":"2013","unstructured":"Obeng-Adjei N, Hutnick NA, Yan J, Chu JS, Myles DJ, Morrow MP, et al. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. Cancer Gene Ther. 2013;20:652\u201362.","journal-title":"Cancer Gene Ther"},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejca.2013.09.016","volume":"50","author":"C Olgasi","year":"2014","unstructured":"Olgasi C, Dentelli P, Rosso A, Iavello A, Togliatto G, Toto V, et al. DNA vaccination against membrane-bound Kit ligand: a new approach to inhibiting tumour growth and angiogenesis. Eur J Cancer. 2014;50:234\u201346.","journal-title":"Eur J Cancer"},{"key":"738_CR15","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.4161\/hv.25013","volume":"9","author":"H Liu","year":"2013","unstructured":"Liu H, Geng S, Feng C, Xie X, Wu B, Chen X, et al. A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model. Hum Vaccin Immunother. 2013;9:2196\u2013202.","journal-title":"Hum Vaccin Immunother"},{"key":"738_CR16","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.4049\/jimmunol.171.9.4920","volume":"171","author":"PP Ho","year":"2003","unstructured":"Ho PP, Fontoura P, Ruiz PJ, Steinman L, Garren H. An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol. 2003;171:4920\u20136.","journal-title":"J Immunol"},{"key":"738_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ki.2012.374","volume":"83","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang YM, Wang Y, Zheng G, Zhang GY, Zhou JJ, et al. DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats. Kidney Int. 2013;83:223\u201332.","journal-title":"Kidney Int"},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molimm.2007.04.008","volume":"44","author":"JF J\u00e9gou","year":"2007","unstructured":"J\u00e9gou JF, Chan P, Schouft MT, Gasque P, Vaudry H, Fontaine M. Protective DNA vaccination against myelin oligodendrocyte glycoprotein is overcome by C3d in experimental autoimmune encephalomyelitis. Mol Immunol. 2007;44:3691\u2013701.","journal-title":"Mol Immunol"},{"key":"738_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/hv.27183","volume":"10","author":"R Weiss","year":"2014","unstructured":"Weiss R, Scheiblhofer S, Thalhamer J. Allergens are not pathogens: Why immunization against allergy differs from vaccination against infectious diseases. Hum Vaccin Immunother. 2014;10:703\u20137.","journal-title":"Hum Vaccin Immunother"},{"key":"738_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000345972","volume":"161","author":"LQ Song","year":"2013","unstructured":"Song LQ, Li Y, Li WN, Zhang W, Qi HW, Wu CG. Safety and immunogenicity of a DNA vaccine encoding human calcium-activated chloride channel 1 (hCLCA1) in asthmatic mice. Int Arch Allergy Immunol. 2013;161:243\u201351.","journal-title":"Int Arch Allergy Immunol"},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.imlet.2013.01.013","volume":"151","author":"P Pulsawat","year":"2013","unstructured":"Pulsawat P, Pitakpolrat P, Prompetchara E, Kaewamatawong T, Techakriengkrai N, Sirivichayakul S, et al. Optimization of a Der p 2-based prophylactic DNA vaccine against house dust mite allergy. Immunol Lett. 2013;151:23\u201330.","journal-title":"Immunol Lett"},{"key":"738_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465\u20138.","journal-title":"Science"},{"key":"738_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/hum.1995.6.5-553","volume":"6","author":"D Lew","year":"1995","unstructured":"Lew D, Parker SE, Latimer T, Abai AM, Kuwahara-Rundell A, Doh SG, et al. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum Gene Ther. 1995;6:553\u201364.","journal-title":"Hum Gene Ther"},{"key":"738_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0169-4758(95)80172-3","volume":"11","author":"GJ Waine","year":"1995","unstructured":"Waine GJ, McManus DP. Nucleic acids: vaccines of the future. Parasitol Today. 1995;11:113\u20136.","journal-title":"Parasitol Today"},{"key":"738_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/978-1-4939-0345-0_38","volume":"1139","author":"J Mairhofer","year":"2014","unstructured":"Mairhofer J, Lara AR. Advances in host and vector development for the production of plasmid DNA vaccines. Methods Mol Biol. 2014;1139:505\u201341.","journal-title":"Methods Mol Biol"},{"key":"738_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1756-3305-7-431","volume":"7","author":"IA Hassan","year":"2014","unstructured":"Hassan IA, Wang S, Xu L, Yan R, Song X, Li X. DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice. Parasit Vectors. 2014;7:431.","journal-title":"Parasit Vectors"},{"key":"738_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1756-3305-6-63","volume":"6","author":"H Cong","year":"2013","unstructured":"Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, et al. Compound DNA vaccine encoding SAG1\/ SAG3 with A2\/B subunit of cholera toxin as a geneticadjuvant protects BALB\/c mice against Toxoplasma gondii. Parasit Vectors. 2013;6:63.","journal-title":"Parasit Vectors"},{"key":"738_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1756-3305-3-109","volume":"3","author":"X Wang","year":"2010","unstructured":"Wang X, Zhang L, Chi Y, Hoellwarth J, Zhou S, Wen X, et al. The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit Vectors. 2010;3:109.","journal-title":"Parasit Vectors"},{"key":"738_CR29","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","volume":"70","author":"N Garg","year":"2002","unstructured":"Garg N, Tarleton R. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun. 2002;70:5547\u201355.","journal-title":"Infect Immun"},{"key":"738_CR30","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1128\/IAI.71.5.2744-2757.2003","volume":"71","author":"SB Boscardin","year":"2003","unstructured":"Boscardin SB, Kinoshita SS, Fujimura AE, Rodrigues MM. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun. 2003;71:2744\u201357.","journal-title":"Infect Immun"},{"key":"738_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1128\/IAI.71.3.1234-1241.2003","volume":"71","author":"Y Miyahira","year":"2003","unstructured":"Miyahira Y, Katae M, Takeda K, Yagita H, Okumura K, Kobayashi S, et al. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect Immun. 2003;71:1234\u201341.","journal-title":"Infect Immun"},{"key":"738_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1348-0421.2006.tb03791.x","volume":"50","author":"JS Mussalem","year":"2006","unstructured":"Mussalem JS, Vasconcelos JR, Squaiella CC, Ananias RZ, Braga EG, Rodrigues MM, et al. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene. Microbiol Immunol. 2006;50:253\u201363.","journal-title":"Microbiol Immunol"},{"key":"738_CR33","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/CVI.00144-08","volume":"15","author":"V Bhatia","year":"2008","unstructured":"Bhatia V, Garg NJ. Previously Unrecognized Vaccine Candidates Control Trypanosoma cruzi Infection and Immunopathology in Mice. Clin Vaccine Immunol. 2008;15:1158\u201364.","journal-title":"Clin Vaccine Immunol"},{"key":"738_CR34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/erv.12.85","volume":"11","author":"E Dumonteil","year":"2012","unstructured":"Dumonteil E, Bottazzi ME, Zhan B, Heffernan MJ, Jones K, Valenzuela JG, et al. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev Vaccines. 2012;11:1043\u201355.","journal-title":"Expert Rev Vaccines"},{"key":"738_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/pim.12017","volume":"35","author":"B Salgado-Jim\u00e9nez","year":"2013","unstructured":"Salgado-Jim\u00e9nez B, Arce-Fonseca M, Bayl\u00f3n-Pacheco L, Talam\u00e1s-Rohana P, Rosales-Encina JL. Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs. Parasite Immunol. 2013;35:32\u201341.","journal-title":"Parasite Immunol"},{"key":"738_CR36","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.7150\/ijbs.7.1230","volume":"7","author":"M Arce-Fonseca","year":"2011","unstructured":"Arce-Fonseca M, Ramos-Ligonio A, L\u00f3pez-Monte\u00f3n A, Salgado-Jim\u00e9nez B, Talam\u00e1s-Rohana P, Rosales-Encina JL. A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease. Int J Biol Sci. 2011;7:1230\u20138.","journal-title":"Int J Biol Sci"},{"key":"738_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1297-9716-44-15","volume":"44","author":"M Arce-Fonseca","year":"2013","unstructured":"Arce-Fonseca M, Ballinas-Verdugo MA, Zenteno ER, Su\u00e1rez-Flores D, Carrillo-S\u00e1nchez SC, Alejandre-Aguilar R, et al. Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model. Vet Res. 2013;44:15.","journal-title":"Vet Res"},{"key":"738_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1297-9716-43-79","volume":"43","author":"O Rodr\u00edguez-Morales","year":"2012","unstructured":"Rodr\u00edguez-Morales O, P\u00e9rez-Leyva MM, Ballinas-Verdugo MA, Carrillo-S\u00e1nchez SC, Rosales-Encina JL, Alejandre-Aguilar R, et al. Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model. Vet Res. 2012;43:79.","journal-title":"Vet Res"},{"key":"738_CR39","doi-asserted-by":"publisher","first-page":"826570","DOI":"10.1155\/2013\/826570","volume":"2013","author":"O Rodr\u00edguez-Morales","year":"2013","unstructured":"Rodr\u00edguez-Morales O, Carrillo-S\u00e1nchez SC, Garc\u00eda-Mendoza H, Aranda-Fraustro A, Ballinas-Verdugo MA, Alejandre-Aguilar R, et al. Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model. Biomed Res Int. 2013;2013:826570.","journal-title":"Biomed Res Int"},{"key":"738_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1286-4579(02)01600-3","volume":"4","author":"AR Schnapp","year":"2002","unstructured":"Schnapp AR, Eickhoff CS, Scharfstein J, Hoft DF. Induction of B- and T-cell respondes to cruzipain in the murine model of Trypanosoma cruzi infection. Microbes Infect. 2002;4:805\u201313.","journal-title":"Microbes Infect"},{"key":"738_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/IAI.01163-07","volume":"76","author":"SI Cazorla","year":"2008","unstructured":"Cazorla SI, Becker PD, Frank FM, Ebensen T, Sartori MJ, Corral RS, et al. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect Immun. 2008;76:324\u201333.","journal-title":"Infect Immun"},{"key":"738_CR42","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/S0264-410X(03)00121-X","volume":"21","author":"BH Fralish","year":"2003","unstructured":"Fralish BH, Tarleton RL. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine. 2003;21:3070\u201380.","journal-title":"Vaccine"},{"key":"738_CR43","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1128\/IAI.73.11.7356-7365.2005","volume":"73","author":"T Miyahira","year":"2005","unstructured":"Miyahira T, Takashima Y, Kobayashi S, Matsumoto Y, Takeuchi T, Ohyanagi-Hara M, et al. Immune response against a single CD8+ -T cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect Immun. 2005;73:7356\u201365.","journal-title":"Infect Immun"},{"key":"738_CR44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/S0031182005009753","volume":"132","author":"GA Garc\u00eda","year":"2006","unstructured":"Garc\u00eda GA, Arnaiz MR, Laucella SA, Esteva MI, Ainciart N, Riarte A, et al. Immunological and pathological responses in BALB\/c mice induced by genetic administration of Tc 13 antigen of Trypanosoma cruzi. Parasitology. 2006;132:855\u201366.","journal-title":"Parasitology"},{"key":"738_CR45","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1016\/j.vaccine.2006.07.006","volume":"24","author":"M Morell","year":"2006","unstructured":"Morell M, Thomas MC, Caballero T, Alonso C, L\u00f3pez MC. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine. 2006;24:7046\u201355.","journal-title":"Vaccine"},{"key":"738_CR46","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.micinf.2006.08.004","volume":"8","author":"E Roffe","year":"2006","unstructured":"Roffe E, Souza AL, Caetano BC, Machado PP, Barcelos LS, Russo RC, et al. A DNA vaccine encoding CCL4\/MIP-1beta enhances myocarditis in experimental Trypanosoma cruzi infection in rats. Microbes Infect. 2006;8:2745\u201355.","journal-title":"Microbes Infect"},{"key":"738_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","volume":"50","author":"G Sanchez-Burgos","year":"2007","unstructured":"Sanchez-Burgos G, Mezquita-Vega RG, Escobedo-Ortegon J, Ramirez-Sierra MJ, Arjona-Torres A, Ouaissi A, et al. Comparative evalutation of therapeutic DNA vaccines against Trypanosoma cruzi in mice. FEMS Immunol Med Microbiol. 2007;50:333\u201341.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"738_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","volume":"72","author":"E Dumonteil","year":"2004","unstructured":"Dumonteil E, Escobedo-Ortegon J, Reyes-Rodriguez N, Arjona-Torres A, Ramirez-Sierra MJ. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect Immun. 2004;72:46\u201353.","journal-title":"Infect Immun"},{"key":"738_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.imlet.2005.11.015","volume":"103","author":"H Zapata-Estrella","year":"2006","unstructured":"Zapata-Estrella H, Hummel-Newell C, Sanchez-Burgos G, Escobedo-Ortegon J, Ramirez-Sierra MJ, Arjona-Torres A, et al. Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice. Immunol Lett. 2006;103:186\u201391.","journal-title":"Immunol Lett"},{"key":"738_CR50","doi-asserted-by":"publisher","first-page":"e1050","DOI":"10.1371\/journal.pntd.0001050","volume":"5","author":"JE Aparicio-Burgos","year":"2011","unstructured":"Aparicio-Burgos JE, Ochoa-Garc\u00eda L, Zepeda-Escobar JA, Gupta S, Dhiman M, Mart\u00ednez JS, et al. Testing the efficacy of a multi-component DNA-prime\/DNA-boost vaccine against Trypanosoma cruzi infection in dogs. PLoS Negl Trop Dis. 2011;5:e1050.","journal-title":"PLoS Negl Trop Dis"},{"key":"738_CR51","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1128\/IAI.01190-10","volume":"79","author":"PO Rigato","year":"2011","unstructured":"Rigato PO, de Alencar BC, de Vasconcelos JR, Dominguez MR, Ara\u00fajo AF, Machado AV, et al. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi. Infect Immun. 2011;79:2120\u201330.","journal-title":"Infect Immun"},{"key":"738_CR52","doi-asserted-by":"publisher","first-page":"e1002699","DOI":"10.1371\/journal.ppat.1002699","volume":"8","author":"JR Vasconcelos","year":"2012","unstructured":"Vasconcelos JR, Bru\u00f1a-Romero O, Ara\u00fajo AF, Dominguez MR, Ersching J, de Alencar BC. Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine. PLoS Pathog. 2012;8:e1002699.","journal-title":"PLoS Pathog"},{"key":"738_CR53","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.1371\/journal.pntd.0000983","volume":"5","author":"CS Eickhoff","year":"2011","unstructured":"Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, et al. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. PLoS Negl Trop Dis. 2011;5:e983.","journal-title":"PLoS Negl Trop Dis"},{"key":"738_CR54","doi-asserted-by":"publisher","first-page":"e59347","DOI":"10.1371\/journal.pone.0059347","volume":"8","author":"RT Nogueira","year":"2013","unstructured":"Nogueira RT, Nogueira AR, Pereira MC, Rodrigues MM, Neves PC, Galler R, et al. Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi. PLoS ONE. 2013;8:e59347.","journal-title":"PLoS ONE"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-015-0738-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0738-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-015-0738-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:05:19Z","timestamp":1630573519000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-015-0738-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s13071-015-0738-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]},"assertion":[{"value":"1 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"121"}}